120 related articles for article (PubMed ID: 22614519)
1. Synergistic effect of malathion and estrogen on mammary gland carcinogenesis.
Calaf GM; Echiburú-Chau C
Oncol Rep; 2012 Aug; 28(2):640-6. PubMed ID: 22614519
[TBL] [Abstract][Full Text] [Related]
2. A rat mammary tumor model induced by the organophosphorous pesticides parathion and malathion, possibly through acetylcholinesterase inhibition.
Cabello G; Valenzuela M; Vilaxa A; Durán V; Rudolph I; Hrepic N; Calaf G
Environ Health Perspect; 2001 May; 109(5):471-9. PubMed ID: 11401758
[TBL] [Abstract][Full Text] [Related]
3. Catechol estrogens as biomarkers for mammary gland cancer.
Calaf GM; Garrido F
Int J Oncol; 2011 Jul; 39(1):177-83. PubMed ID: 21503573
[TBL] [Abstract][Full Text] [Related]
4. Organophosphorous pesticides in breast cancer progression.
Cabello G; Juarranz A; Botella LM; Calaf GM
J Submicrosc Cytol Pathol; 2003 Jan; 35(1):1-9. PubMed ID: 12762645
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation and tumor formation induced by eserine, an acetylcholinesterase inhibitor, in rat mammary gland.
Calaf GM; Parra E; Garrido F
Oncol Rep; 2007 Jan; 17(1):25-33. PubMed ID: 17143474
[TBL] [Abstract][Full Text] [Related]
6. Rat lung cancer induced by malathion and estrogen.
Echiburú-Chau C; Calaf GM
Int J Oncol; 2008 Sep; 33(3):603-11. PubMed ID: 18695892
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ
Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
[TBL] [Abstract][Full Text] [Related]
8. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
9. Role of organophosphorous pesticides and acetylcholine in breast carcinogenesis.
Calaf GM
Semin Cancer Biol; 2021 Nov; 76():206-217. PubMed ID: 33766648
[TBL] [Abstract][Full Text] [Related]
10. Organophosphorous pesticides and estrogen induce transformation of breast cells affecting p53 and c-Ha-ras genes.
Calaf GM; Echiburu-Chau C; Roy D
Int J Oncol; 2009 Nov; 35(5):1061-8. PubMed ID: 19787260
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of rat kidney induced by environmental substances and estrogen.
Alfaro-Lira S; Pizarro-Ortiz M; Calaf GM
Int J Environ Res Public Health; 2012 May; 9(5):1630-48. PubMed ID: 22754462
[TBL] [Abstract][Full Text] [Related]
12. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
14. Effects of prepubertal zeranol exposure on estrogen target organs and N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Yuri T; Nikaido Y; Shimano N; Uehara N; Shikata N; Tsubura A
In Vivo; 2004; 18(6):755-61. PubMed ID: 15646816
[TBL] [Abstract][Full Text] [Related]
15. Alterations in c-Src/HER1 and estrogen receptor α signaling pathways in mammary gland and tumors of hexachlorobenzene-treated rats.
Peña D; Pontillo C; García MA; Cocca C; Alvarez L; Chiappini F; Bourguignon N; Frahm I; Bergoc R; Kleiman de Pisarev D; Randi A
Toxicology; 2012 Mar; 293(1-3):68-77. PubMed ID: 22245120
[TBL] [Abstract][Full Text] [Related]
16. Mammary gland morphology in Sprague-Dawley rats following treatment with an organochlorine mixture in utero and neonatal genistein.
Foster WG; Younglai EV; Boutross-Tadross O; Hughes CL; Wade MG
Toxicol Sci; 2004 Jan; 77(1):91-100. PubMed ID: 14514955
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH
Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
[TBL] [Abstract][Full Text] [Related]
19. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene.
Russo IH; Russo J
J Natl Cancer Inst; 1978 Dec; 61(6):1439-49. PubMed ID: 102856
[TBL] [Abstract][Full Text] [Related]
20. Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer.
Swanson SM; Whitaker LM; Stockard CR; Myers RB; Oelschlager D; Grizzle WE; Juliana MM; Grubbs CJ
Anticancer Res; 1997; 17(6D):4639-45. PubMed ID: 9494582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
